Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Non-Current Deffered Revenue (2019 - 2021)

INVO Fertility (IVF) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $2.3 million as the latest value for Q3 2021.

  • On a quarterly basis, Non-Current Deffered Revenue fell 23.53% to $2.3 million in Q3 2021 year-over-year; TTM through Sep 2021 was $2.3 million, a 23.53% decrease, with the full-year FY2020 number at $2.9 million, down 20.0% from a year prior.
  • Non-Current Deffered Revenue was $2.3 million for Q3 2021 at INVO Fertility, down from $2.5 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $3.9 million in Q2 2019 to a low of $2.3 million in Q3 2021.
  • A 3-year average of $3.1 million and a median of $3.1 million in 2020 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: dropped 18.18% in 2020, then fell 23.53% in 2021.
  • INVO Fertility's Non-Current Deffered Revenue stood at $3.6 million in 2019, then fell by 20.0% to $2.9 million in 2020, then decreased by 18.75% to $2.3 million in 2021.
  • Per Business Quant, the three most recent readings for IVF's Non-Current Deffered Revenue are $2.3 million (Q3 2021), $2.5 million (Q2 2021), and $2.7 million (Q1 2021).